Research records indexed for AOD9604

This page carries all 11 records that the literature query returned for AOD9604. Every row resolves to a real identifier and names the study model, so no finding reads as a human claim by default. The compound page is AOD9604.

Indexed records

Records retrieved for AOD9604, newest first
RecordYearStudy typeModeln as statedWhat it reported
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration pmid:423951762026review-article, ReviewotherNot statedIndexed as review-article, review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Human Growth Hormone; Peptides; Insulin-Like Growth Factor I; Self Administration; Growth Hormone-Releasing Hormone.
Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices pmid:423287382026Journal ArticleotherNot statedIndexed as journal article. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Peptides; Doping In Sports; Limit Of Detection; Dried Blood Spot Testing; Liquid Chromatography-Mass Spectrometry.
Detection and in vitro metabolism of AOD9604 pmid:252085112015Validation Study, Research Support, N.I.H., ExtramuralotherNot statedIndexed as validation study, research support, n.i.h., extramural. study model from MeSH "Humans" with no interventional publication type. subject headings: Somatostatin; Peptide Fragments; Chromatography, Liquid; Substance Abuse Detection; Doping In Sports.
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model pmid:262756942015Journal ArticlerodentNot statedIndexed as journal article. study model from MeSH "Disease Models, Animal". subject headings: Rabbits; Osteoarthritis; Disease Models, Animal; Somatostatin; Collagenases.
Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604 pmid:249761182014LetterotherNot statedIndexed as letter. study model from assigned MeSH headings do not state a study model. subject headings: Somatostatin; Peptides; Peptide Fragments; Pharmaceutical Preparations; Chromatography, Liquid.
Current updates in the medical management of obesity pmid:224353922012ReviewotherNot statedIndexed as review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Obesity; Anti-Obesity Agents; Appetite Depressants; Hypoglycemic Agents.
[Obesity: a review of currently used antiobesity drugs and new compounds in clinical development] pmid:179717632007ReviewotherNot statedIndexed as review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Obesity; Cyclobutanes; Lactones; Piperidines; Pyrazoles.
Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors pmid:169314962006ReviewotherNot statedIndexed as review. compound named in the abstract, not the title. study model from MeSH "Humans" with no interventional publication type. subject headings: Cardiovascular Diseases; Obesity; Weight Loss; Anti-Obesity Agents; Appetite Depressants.
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice pmid:117132132001Research Support, Non-U.S. Gov'trodentNot statedIndexed as research support, non-u.s. gov't. study model from MeSH "Mice, Inbred C57bl". subject headings: Adipose Tissue; Mice, Inbred C57BL; Mice, Knockout; Obesity; Body Weight.
Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment pmid:116737632001Comparative Study, Research Support, Non-U.S. Gov'trodentNot statedIndexed as comparative study, research support, non-u.s. gov't. compound named in the abstract, not the title. study model from MeSH "Mice, Inbred C57bl". subject headings: Adipose Tissue; Cells, Cultured; Mice, Inbred C57BL; Mice, Obese; Obesity.
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone pmid:111463672000Journal ArticlerodentNot statedIndexed as journal article. study model from MeSH "Rats". subject headings: Adipose Tissue; Rats, Zucker; Obesity; Weight Gain; Insulin.

Where this page sits

Compound page: AOD9604. Class: Growth hormone secretagogues.

Retrieved 2026-10-10.

Sources

  1. PubChem Compound Summary for CID 71300630, Aod-9604. PubChem, National Library of Medicine (2026). pubchem:71300630
  2. Drugs@FDA application register query for this compound, no application records returned. U.S. Food and Drug Administration, openFDA drugsfda endpoint (2026). fda:aod-9604
  3. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice. Endocrinology (2001). pmid:11713213
  4. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone. Hormone research (2000). pmid:11146367
  5. Detection and in vitro metabolism of AOD9604. Drug testing and analysis (2015). pmid:25208511
  6. Identification and characterization of peptide drugs in unknown pharmaceutical preparations seized by the Belgian authorities: case report on AOD9604. Drug testing and analysis (2014). pmid:24976118
  7. AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug testing and analysis (2013). pmid:24124033
  8. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model. Annals of clinical and laboratory science (2015). pmid:26275694

On each stated value was matched to the record cited for it. That is record matching, not an appraisal of the research. Compiled and checked by: Peptide Monographs editorial desk. No qualified clinical reviewer.

Related resources